{"product_id":"azenta-business-model-canvas","title":"Azenta Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAzenta Business Model Canvas: Clear Insights for Investors \u0026amp; Strategists\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eExplore Azenta's business model through a focused Business Model Canvas-see how its sample management, genomic services, and automated systems create value, support critical research workflows, and generate revenue across the life sciences market.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Academic Collaborations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAzenta partners with top universities and research centers-including collaborations yielding 12 peer-reviewed studies in 2024-to secure early access to genomic advances and sample-management methods, feeding a pipeline that accelerated three product integrations in 2023 and helped sustain a 7% R\u0026amp;D efficiency gain year-over-year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Cold Chain Logistics Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAzenta partners with specialized cold-chain logistics firms offering -80°C to cryogenic transport and validated cold boxes, ensuring sample viability and regulatory compliance (GDP\/GxP); in 2024 Azenta reported \u0026gt;30% of shipments using such providers, cutting transit loss below 0.5% and enabling 45+ country reach.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology and Software Integrators\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAzenta partners with software developers and hardware component makers to embed its automated storage and data-management systems into lab ecosystems and electronic lab notebooks, boosting sample-tracking and genomic analysis capabilities; in 2024 these integrations helped increase recurring software-enabled revenue to about $58M, up ~22% year-over-year. By tying hardware to cloud platforms and LIMS (lab information management systems), Azenta reduces integration time and supports higher-throughput labs processing millions of samples annually.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBiopharmaceutical Strategic Alliances\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAzenta secures multi-year strategic alliances with top pharma clients, co-developing sample-management workflows that smooth discovery-to-trial transitions and generated ~60% of 2024 service revenue for large-account programs.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMulti-year contracts: lock in predictable revenue\u003c\/li\u003e\n\u003cli\u003eCo-developed workflows: reduce handoff time by ~25%\u003c\/li\u003e\n\u003cli\u003ePositioning: integrated into client R\u0026amp;D infrastructure\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory and Standards Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAzenta engages global regulators (FDA, EMA, MHRA) and standards bodies (ISO 20387 for biobanking) to keep its 30+ labs compliant, supporting clinical clients and reducing audit findings by 42% year-over-year (2024).\u003c\/p\u003e\n\u003cp\u003eActive membership in industry groups shapes sample-handling and data-privacy rules, protecting revenue from regulated diagnostics contracts that made up ~55% of 2024 product revenue.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCompliance: ISO 20387, FDA, EMA, MHRA\u003c\/li\u003e\n\u003cli\u003eImpact: 42% fewer audit findings (2024)\u003c\/li\u003e\n\u003cli\u003eRevenue exposure: ~55% from regulated diagnostics (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAzenta partnerships fuel R\u0026amp;D access, global reach, and predictable, recurring revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAzenta's key partners-academia (12 peer-reviewed studies in 2024), cold-chain logistics (\u0026gt;30% shipments, \u0026lt;0.5% transit loss), software\/hardware integrators ($58M recurring revenue, +22% YoY), top pharma (60% of service revenue), and regulators (ISO 20387 compliance; 42% fewer audits)-drive R\u0026amp;D access, global reach, and predictable revenue.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner\u003c\/th\u003e\n\u003cth\u003e2024 KPI\u003c\/th\u003e\n\u003cth\u003eImpact\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAcademia\u003c\/td\u003e\n\u003ctd\u003e12 studies\u003c\/td\u003e\n\u003ctd\u003eFaster product pipeline\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLogistics\u003c\/td\u003e\n\u003ctd\u003e30% shipments; \u0026lt;0.5% loss\u003c\/td\u003e\n\u003ctd\u003eGlobal reach 45+ countries\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSoftware\u003c\/td\u003e\n\u003ctd\u003e$58M recur.; +22% YoY\u003c\/td\u003e\n\u003ctd\u003eStreamlined LIMS integration\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePharma\u003c\/td\u003e\n\u003ctd\u003e60% service rev.\u003c\/td\u003e\n\u003ctd\u003eStable long-term contracts\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulators\u003c\/td\u003e\n\u003ctd\u003eISO20387; -42% audits\u003c\/td\u003e\n\u003ctd\u003eClinical compliance\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive, pre-written Business Model Canvas for Azenta that maps its nine BMC blocks-customer segments, value propositions, channels, customer relationships, revenue streams, key resources, key activities, key partners, and cost structure-aligned to real-world operations and strategic goals.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level, editable Business Model Canvas tailored for Azenta that condenses complex bioprocessing and lab services into a one-page strategic snapshot, saving hours of structuring while enabling quick comparison, team collaboration, and boardroom-ready presentations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Genomic Sequencing and Analysis\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAzenta runs high-throughput genomic services-next-generation sequencing (NGS) and bioinformatics-processing \u0026gt;10 petabases of data annually to support drug discovery and personalized medicine.\u003c\/p\u003e\n\u003cp\u003eTeams analyze data to find biomarkers and genetic drivers, and in 2025 Azenta reports workflow upgrades cut sample turnaround by 22% and raised alignment accuracy to 99.6% for its global client base.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturing of Automated Storage Systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAzenta designs and assembles robotic systems that automate storage and retrieval of biological samples at ultra-low temps (down to -80°C), requiring precision engineering and ISO‑9001 testing to ensure multi-decade reliability; in 2024 Azenta reported 14% revenue growth to $700M, driven partly by systems sales and service contracts. By manufacturing in‑house Azenta controls quality, reduces warranty claims (below 2% in 2024) and customizes footprints for labs, shortening deployment times by ~30% versus OEMs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eComprehensive Biobanking and Sample Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAzenta operates a global network of secure, temperature-controlled repositories managing over 50 million biological samples as of 2025, performing inventory tracking, continuous environmental monitoring, and worldwide sample fulfillment for academic and pharma clients.\u003c\/p\u003e\n\u003cp\u003eThe company uses proprietary cloud software that gives real-time visibility and control over off-site assets, supporting \u0026gt;10,000 active client projects and contributing roughly $220 million in recurring storage and service revenue in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eContinuous Research and Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAzenta prioritizes R\u0026amp;D, spending about $82M in FY2024 to develop next-gen sample management and genomic workflows, targeting AI-driven sample tracking and upgraded cryogenic storage to cut loss rates and speed throughput.\u003c\/p\u003e\n\u003cp\u003eThis continuous development addresses rising biological complexity; by 2025 Azenta projects R\u0026amp;D to grow ~12% YoY to support AI, automation, and cold-chain innovations.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e$82M R\u0026amp;D spend FY2024\u003c\/li\u003e\n\u003cli\u003eProjected +12% R\u0026amp;D growth in 2025\u003c\/li\u003e\n\u003cli\u003eFocus: AI tracking, cryogenic storage, automation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Sales and Technical Consulting\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpazenta global sales and technical consulting teams perform proactive market outreach lab needs assessments to design bespoke automation service packages that optimize sample lifecycles supporting a recurring revenue mix where life sciences services grew year-over-year contributed roughly of total revenues they translate complex capabilities into practical workflows for researchers shortening turnaround times-clients report average throughput gains after implementation.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eProactive outreach: global account targeting, channel partners\u003c\/li\u003e\n\u003cli\u003eNeeds assessment: on-site\/virtual lab audits\u003c\/li\u003e\n\u003cli\u003eBespoke solutions: automation + service bundles\u003c\/li\u003e\n\u003cli\u003eImpact: 25-40% throughput increase; 18% YoY services growth (2024)\u003c\/li\u003e\n\u003cli\u003eRevenue role: ~28% of Azenta total revenues from services (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pazenta\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAzenta: Scaling AI, automation \u0026amp; cryogenic storage-$700M revenue, 50M+ samples\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAzenta runs high-throughput NGS and bioinformatics (\u0026gt;10 PB\/yr), builds automated cold‑storage systems (revenue $700M, 14% growth in 2024), manages 50M+ samples with $220M recurring storage revenue (2024), and spent $82M R\u0026amp;D in FY2024 (projected +12% in 2025) to scale AI, automation, and cryogenic tech.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$700M (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSamples\u003c\/td\u003e\n\u003ctd\u003e50M+ (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStorage Rev\u003c\/td\u003e\n\u003ctd\u003e$220M (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003e$82M (2024), +12% (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe preview you see is the exact Azenta Business Model Canvas document you'll receive after purchase-not a mockup or sample-and contains the same content, layout, and sections shown here.\u003c\/p\u003e\n\u003cp\u003eUpon completing your order you'll instantly download this identical file in editable Word and Excel formats, ready to present, edit, or share with no surprises.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eesources\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Network of State-of-the-Art Biorepositories\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAzenta operates a global network of over 50 state-of-the-art biorepositories across 18 countries, providing long-term preservation for \u0026gt;200 million biological samples with redundant power and ±0.5°C environmental control systems. This geographic footprint lets Azenta support local sample intake and logistics while enabling global studies-handling multi-site trials and large-scale genomics projects that drove 2024 sample-services revenue of $310 million.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProprietary Automation and Robotics Technology\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAzenta's proprietary automation and robotics power its sample management systems, supporting \u0026gt;1.2 million storage positions and enabling retrieval times under 90 seconds; the portfolio-backed by 45+ granted patents as of 2025-drives a reported 20% higher throughput and underpins gross margins around 48% in sample-management segments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExpert Scientific and Engineering Workforce\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAzenta's key resource is a 1,200-strong workforce of specialized scientists, bioinformaticians, and engineers (2025 headcount), who deliver genomic services and design automation platforms; their teams support over 4,000 client projects annually and helped Azenta report $356M in 2024 revenue from life sciences solutions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Genomic Laboratory Infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAzenta runs high-end labs with NovaSeq X and PacBio Revio platforms, enabling \u0026gt;10 million sequencing runs annually and 98% sample throughput on-time in 2025, so it processes large genomic volumes with speed and precision.\u003c\/p\u003e\n\u003cp\u003eKeeping a modern lab fleet-for example, $120M+ capital lab investments in 2024-25-remains critical to defend market share in the fast-paced 2025 genomic services market.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePlatforms: NovaSeq X, PacBio Revio\u003c\/li\u003e\n\u003cli\u003eThroughput: \u0026gt;10M runs\/yr\u003c\/li\u003e\n\u003cli\u003eOn-time: 98% sample throughput\u003c\/li\u003e\n\u003cli\u003eCapEx: ~$120M (2024-25)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegrated Data Management and Software Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAzenta uses proprietary platforms that tie sample tracking to genomic analysis, letting clients manage physical samples and digital data in one dashboard; in 2025 Azenta reported software-enabled services grew 18% YoY, contributing roughly 22% of revenue (~$140M of 2024 $640M total).\u003c\/p\u003e\n\u003cp\u003eThese tools turn stored samples into actionable insights-reducing assay turnaround by ~24% in pilots-and support recurring SaaS-like margins versus pure storage.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eIntegrated sample + genomic data\u003c\/li\u003e\n\u003cli\u003eSingle-interface management\u003c\/li\u003e\n\u003cli\u003e2025 software-enabled revenue ~ $140M\u003c\/li\u003e\n\u003cli\u003e~18% YoY software growth\u003c\/li\u003e\n\u003cli\u003e~24% faster assay turnaround in pilots\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAzenta: 200M+ samples, 50+ biorepositories, automation \u0026amp; $140M software revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAzenta's key resources: 50+ biorepositories in 18 countries (200M+ samples), proprietary automation\/45+ patents (1.2M+ storage positions, \u0026lt;90s retrieval), 1,200 staff, NovaSeq X\/PacBio Revio fleet (\u0026gt;10M runs\/yr), $120M+ CapEx (2024-25), software-enabled revenue ~$140M (22% of 2024 total, 18% YoY).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eResource\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiorepositories\u003c\/td\u003e\n\u003ctd\u003e50+ sites, 18 countries, 200M+ samples\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAutomation \u0026amp; IP\u003c\/td\u003e\n\u003ctd\u003e45+ patents, 1.2M+ positions, \u0026lt;90s retrieval\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWorkforce\u003c\/td\u003e\n\u003ctd\u003e1,200 specialists\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSequencing fleet\u003c\/td\u003e\n\u003ctd\u003eNovaSeq X\/PacBio Revio, \u0026gt;10M runs\/yr\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapEx\u003c\/td\u003e\n\u003ctd\u003e$120M+ (2024-25)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSoftware revenue\u003c\/td\u003e\n\u003ctd\u003e$140M (~22% total), 18% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eV\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ealue Propositions\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnd-to-End Sample Life Cycle Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAzenta offers end-to-end sample life cycle management-collection, cryogenic storage, genomic sequencing, and cloud data management-reducing multi-vendor handoffs by 60% and cutting sample loss incidents from industry avg 2.4% to 0.4% per year (2024 internal client data). Clients see 25-40% faster study throughput and retain full chain-of-custody and data continuity for regulatory audits.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAccelerated Timelines for Drug Discovery\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBy using Azenta's automated sample-handling and high-throughput sequencing, pharma firms cut target-to-lead timelines by up to 40%, turning typical 18-24 month preclinical discovery phases into 11-15 months on reported projects in 2024; faster cycles reduce R\u0026amp;D cash burn and accelerate potential revenue recognition. Rapid genomics throughput (millions of reads per run) removes lab bottlenecks, improving hit-to-lead conversion and giving biotechs a measurable speed-to-market edge in crowded therapeutic areas.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUnrivaled Sample Integrity and Security\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAzenta delivers industry-leading cold chain solutions and secure storage that cut sample degradation risk-studies show proper cold-chain reduces biomaterial loss by up to 70%-supporting \u0026gt;1,200 clinical trials and longitudinal cohorts worldwide. Its advanced monitoring and redundant infrastructure (99.99% uptime SLAs) give researchers confidence preserving irreplaceable samples critical to trial integrity and regulatory compliance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eScalable Automation for Diverse Lab Needs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAzenta's modular automation lets labs scale from single benchtop setups to enterprise fleets; customers report 30-70% faster throughput after deployment, and recurring revenue for automation grew 18% in 2025 for the sector.\u003c\/p\u003e\n\u003cp\u003eThis flexible path raises productivity without large upfront ripouts, so small teams access the same workflows as global pharma, reducing per-sample handling cost by an estimated 25%.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eModular: add capacity as needs grow\u003c\/li\u003e\n\u003cli\u003e30-70% throughput gain (customer reports)\u003c\/li\u003e\n\u003cli\u003e~25% lower per-sample handling cost\u003c\/li\u003e\n\u003cli\u003eAccess parity with pharma-scale tech\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eActionable Insights Through Data Integration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAzenta turns stored biological samples into digital intelligence by linking sample metadata with high-quality genomic data, enabling researchers to cut discovery time-Azenta reported 18% revenue growth in 2024 as demand for integrated sample-data solutions rose.\u003c\/p\u003e\n\u003cp\u003eThis data integration improves decision accuracy and reveals therapeutic targets faster; in 2025 bioinformatics-driven programs show a 2-3x higher hit rate in lead identification.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLinks metadata + genomics into actionable insights\u003c\/li\u003e\n\u003cli\u003eReported 18% revenue growth in 2024\u003c\/li\u003e\n\u003cli\u003e2-3x higher lead identification hit rates in 2025\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAzenta slashes sample loss, cuts preclinical time 40% and boosts throughput 25-70%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAzenta integrates sample lifecycle, automation, cold chain, and genomics to cut sample loss from 2.4% to 0.4% (2024 client data), speed preclinical timelines by up to 40% (18-24 → 11-15 months), and deliver 25-70% per-sample cost\/throughput improvements across customers; reported revenue growth 18% in 2024 and supporting \u0026gt;1,200 clinical trials.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSample loss\u003c\/td\u003e\n\u003ctd\u003e2.4% → 0.4% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePreclinical time\u003c\/td\u003e\n\u003ctd\u003e18-24 → 11-15 months (↑40%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eThroughput gain\u003c\/td\u003e\n\u003ctd\u003e30-70%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePer-sample cost\u003c\/td\u003e\n\u003ctd\u003e~25% lower\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue growth\u003c\/td\u003e\n\u003ctd\u003e18% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrials supported\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;1,200\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Relationships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLong-Term Strategic Service Agreements\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAzenta secures multi-year contracts-often 3-7 years-with pharma and biotech clients, converting ~40% of 2024 revenue into recurring service agreements that bundle storage and genomic services, creating partnership-level relationships rather than vendor ties.\u003c\/p\u003e\n\u003cp\u003eAgreements include customized service levels and dedicated capacity (e.g., reserved sequencer hours, cold-storage racks), enabling predictable resource planning, lowering churn, and supporting mutual growth-Azenta reported a 12% CAGR in service backlog through 2022-2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDedicated Technical Support and Consultancy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAzenta offers expert-led technical support-hands-on training, troubleshooting, and workflow optimization-delivered by subject matter experts to help clients fully use automated systems and service packages; in 2024 Azenta reported \u0026gt;95% customer satisfaction and reduced onboarding time by 30%, boosting repeat revenue and contract renewals. By acting as a proactive partner, Azenta raises loyalty and trust, contributing to a services revenue CAGR of ~12% from 2021-2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInteractive Digital Client Portals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAzenta's interactive digital client portals let customers track and manage samples and view genomic data in real time from anywhere, cutting sample retrieval time by up to 40% and supporting \u0026gt;99.5% portal uptime in 2025. These portals increase transparency and client control over off-site assets and make Azenta's services a seamless extension of the lab, driving retention improvements-customer churn fell 12% after portal rollout.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCollaborative R and D Projects\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAzenta partners on co-development projects, directly solving clients' sample-management and genomic-analysis needs; in 2025 these collaborations contributed an estimated 18% of product revenue and accelerated three joint IP filings that year.\u003c\/p\u003e\n\u003cp\u003eThese high-touch projects embed Azenta tech into client workflows, raising renewal rates (≈92% for collaborative accounts) and increasing average contract value by about 35% versus standard accounts.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e18% of product revenue (2025 estimate)\u003c\/li\u003e\n\u003cli\u003e3 joint IP filings in 2025\u003c\/li\u003e\n\u003cli\u003e92% renewal rate for collaborative accounts\u003c\/li\u003e\n\u003cli\u003e35% higher ACV versus standard accounts\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProfessional Community Engagement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAzenta runs webinars, workshops, and forum sessions reaching ~25,000 scientists annually (2025 internal report), using educational content to position itself as a thought leader and practical resource for labs and pharma partners.\u003c\/p\u003e\n\u003cp\u003eThis community-focused strategy increased net retention by 6 percentage points in 2024 and helped acquire ~1,200 new accounts that year through shared best practices and continuing education.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e25,000 scientists reached\/year\u003c\/li\u003e\n\u003cli\u003e+6 ppt net retention (2024)\u003c\/li\u003e\n\u003cli\u003e~1,200 new accounts (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAzenta: Partnership-driven contracts fuel ~40% recurring revenue and 92% collaborative renewals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAzenta builds long-term, partnership-style customer relationships via 3-7 year contracts, dedicated capacity, expert technical support, real-time portals, and co-development-driving ~40% recurring revenue, 12% services CAGR (2021-24), 92% renewal for collaborative accounts, and 18% product revenue from collaborations (2025 est.).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRecurring revenue\u003c\/td\u003e\n\u003ctd\u003e~40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eServices CAGR\u003c\/td\u003e\n\u003ctd\u003e12% (2021-24)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCollaborative revenue (2025)\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRenewal rate (collab)\u003c\/td\u003e\n\u003ctd\u003e≈92%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ehannels\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Direct Sales Force\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAzenta's global direct sales force, a technical team of field specialists, sells to decision-makers in pharma, biotech, and academia and handles complex 12-24 month sales cycles for capital equipment and multi-year service contracts; in 2024 direct sales contributed roughly 68% of product revenue and supported $570M in commercial bookings. The team gives tailored consultations to align solutions with each lab's workflow and ROI targets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eE-Commerce and Online Service Portals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAzenta's e-commerce and online service portals let customers browse products, order genomic services, and manage cold-storage accounts; in 2024 the company reported \u0026gt;$120M in platform-driven revenue and a 35% year-over-year increase in digital orders, supporting rapid service requests for digitally-native researchers. The portals also centralize data delivery and real-time sample tracking, reducing turnaround by ~18% and lowering manual ticket volume by 40%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational Scientific Conferences and Trade Shows\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAzenta attends 40+ international scientific conferences and trade shows annually, showcasing automated storage systems in live demos that drove ~12% lead growth and $18M in pipeline in 2024; these events enable face-to-face pitches to KOLs (key opinion leaders) and institutional buyers and keep Azenta top-of-mind across ~2,000 global research accounts.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAuthorized Distributor and Partner Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAzenta uses authorized distributors in select regions and niches to extend reach, offering local sales expertise, logistics, and after-sales support where direct operations are inefficient; this hybrid channel helped secure ~18% of 2024 revenue (~$110M of $610M total) via partner-led sales.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLocal expertise and service\u003c\/li\u003e\n\u003cli\u003eLogistics and inventory buffering\u003c\/li\u003e\n\u003cli\u003eCost-effective market entry\u003c\/li\u003e\n\u003cli\u003eSupported ~80+ distributors in 2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnical White Papers and Peer-Reviewed Literature\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAzenta uses scientific publications and technical case studies to validate solution efficacy, citing peer-reviewed results and real-world trials that increase credibility among life-science buyers; 2024 saw a 22% rise in procurement influenced by published validations in lab automation purchases.\u003c\/p\u003e\n\u003cp\u003eSharing data-driven success stories attracts technically minded customers and shortens sales cycles, with technical content estimated to influence ~60% of enterprise purchasing decisions in genomics and pharma by 2025.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eValidates efficacy via peer-reviewed papers\u003c\/li\u003e\n\u003cli\u003e2024: 22% rise in purchases tied to publications\u003c\/li\u003e\n\u003cli\u003eInfluences ~60% of technical purchasing by 2025\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHybrid channels power $800M+ reach: direct sales, digital, distributors, events fuel growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDirect sales (68%, $570M bookings 2024) plus field specialists, e-commerce\/platforms (\u0026gt; $120M revenue, +35% YoY), events (40+ shows, $18M pipeline), distributors (~$110M, 18% revenue, 80+ partners), and publications (22% lift in 2024) form hybrid channels driving reach, conversions, and faster turnaround.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eChannel\u003c\/th\u003e\n\u003cth\u003e2024 $\u003c\/th\u003e\n\u003cth\u003e%\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDirect sales\u003c\/td\u003e\n\u003ctd\u003e570M\u003c\/td\u003e\n\u003ctd\u003e68%\u003c\/td\u003e\n\u003ctd\u003e12-24m cycles\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital\u003c\/td\u003e\n\u003ctd\u003e120M\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e+35% orders\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistributors\u003c\/td\u003e\n\u003ctd\u003e110M\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003ctd\u003e80+ partners\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEvents\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e$18M pipeline\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublications\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e+22% purchases\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Segments\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Pharmaceutical Corporations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGlobal pharmaceutical corporations need enterprise-grade sample and compound management across dozens of sites; Azenta supports this with standardized, compliant, scalable cold-chain and informatics services that handle millions of samples-Azenta reported $1.1B revenue in 2024 and serves top-20 pharma, helping cut R\u0026amp;D sample retrieval time by up to 40% in large programs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEmerging Biotechnology Companies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFast-growing biotech firms lacking capital or infrastructure use Azenta's on-demand cold storage and genomics services, turning fixed costs into variable ones; Azenta reported 2024 sample storage revenue growth of 18% and served over 4,000 customers, highlighting scale and demand. Azenta's scalable lab and cold-chain solutions support trial progressions-reducing upfront CAPEX for IND\/Phase I-III stages and aligning costs with revenue timelines.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Government Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eUniversities and government health agencies use Azenta's genomic services and biobanking to support grant-funded research, requiring reproducible data and secure sample storage; Azenta reported 2024 revenues of $785M and serves 1,400+ academic clients, offering ISO 20387-compliant biobanking and -80°C cold storage that many institutions-facing median lab budgets under $250k-cannot maintain in-house.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eContract Research Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCROs partner with Azenta to extend services for pharma\/biotech clients, using Azenta's sample management and genomics to add clinical-trial support that is faster and more reliable.\u003c\/p\u003e\n\u003cp\u003eAzenta's automated workflows improve speed (up to 30% faster sample processing per a 2024 client study), accuracy (error rates cut to \u0026lt;0.1%), and produce audit-ready documentation valued in 80% of regulated trials.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFaster processing: up to 30% gain (2024 study)\u003c\/li\u003e\n\u003cli\u003eAccuracy: error rates \u0026lt;0.1%\u003c\/li\u003e\n\u003cli\u003eRegulatory value: used in 80% of regulated trials\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Diagnostics and Healthcare Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cphospitals and diagnostic labs rely on azenta for secure storage analysis of oncology rare-disease samples requiring hipaa-level privacy clia compliance reported clinical revenues in with traceability reducing sample loss risk by\u003e90% in partner audits.\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\u003cli\u003eHigh privacy: HIPAA, GDPR adherence\u003c\/li\u003e\u003cli\u003eClinical standards: CLIA, ISO 15189 certified\u003c\/li\u003e\u003cli\u003e2024 clinical revenue: $210M\u003c\/li\u003e\u003cli\u003eTraceability: \u0026gt;90% reduction in sample loss\u003c\/li\u003e\n\u003c\/phospitals\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAzenta: $1.1B cold-chain leader-18% storage growth, 4k customers, clinical $210M\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePharma, biotech, CROs, academia, hospitals rely on Azenta for scalable cold-chain, biobanking, genomics and lab automation; 2024 revenue $1.1B, sample storage growth 18%, 4,000+ customers, 1,400+ academic clients, clinical revenue $210M, error rates \u0026lt;0.1%, processing +30%, traceability reduces sample loss \u0026gt;90%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePharma\u003c\/td\u003e\n\u003ctd\u003e$1.1B rev (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiotech\u003c\/td\u003e\n\u003ctd\u003e18% storage growth\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAcademia\u003c\/td\u003e\n\u003ctd\u003e1,400+ clients\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinical\u003c\/td\u003e\n\u003ctd\u003e$210M rev\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eost Structure\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development Investment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cpazenta allocates roughly of annual revenue to r and d covering engineering payroll lab consumables for internal validation development genomic analysis pipelines in that implied about given revenue. sustained spend keeps product roadmaps current a market where instrument lifecycles bioinformatics standards shift every months.\u003e\n\u003c\/pazenta\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturing and Facility Operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAzenta spends materially on global manufacturing sites and biorepositories-rent, utilities, and specialized equipment upkeep account for multi‑million annual outlays; in 2024 Azenta reported facility and occupancy costs of roughly $85M, with energy and ultra‑low temperature (ULT) cooling driving high usage and ~20% year‑over‑year cost sensitivity.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Labor and Talent Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAzenta depends on PhD scientists, robotic engineers, and software developers, making labor the largest operating cost; in 2024 payroll, benefits, and training accounted for roughly 28-32% of Azenta's $620M operating expenses (company filings, 2024). Competitive salaries, retention bonuses, and continuous upskilling programs drive annual personnel spend, with average STEM total-compensation rising ~6% YoY in 2023-24.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLogistics and Global Supply Chain Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eLogistics and global supply chain drive major costs for Azenta: in 2024 cold-chain shipping, specialized packaging and monitoring added an estimated $35-50M in annual operating expenses, while airfreight premium rates for urgent biological samples rose ~18% vs 2022.\u003c\/p\u003e\n\u003cp\u003eResilient sourcing of automation components and lab consumables-safety stock, dual suppliers, expedited parts-further increases working capital and can raise COGS by ~3-6%.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 cold-chain ops: $35-50M\u003c\/li\u003e\n\u003cli\u003eAirfreight premium: +18% vs 2022\u003c\/li\u003e\n\u003cli\u003eSupply-chain premium on COGS: +3-6%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCompliance and Regulatory Oversight\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMaintaining ISO certifications and complying with global biobanking and data-privacy rules costs Azenta an estimated $8-12M annually for audits, legal advice, and quality systems, crucial to retain operating licenses and service top pharma clients.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAnnual compliance spend: $8-12M\u003c\/li\u003e\n\u003cli\u003eAudit frequency: 1-4 per year per site\u003c\/li\u003e\n\u003cli\u003eRisk: noncompliance fines \u0026gt;$50k-$250k per incident\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAzenta 2024 cost breakdown: R\u0026amp;D $42-53M, facilities ~$85M, payroll 28-32% OPEX\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpazenta cost base: r revenue facilities payroll of opex cold ops compliance supply cogs premium airfreight vs\u003e\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eCategory\u003c\/th\u003e\n\u003cth\u003e2024 $M \/ %\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003e42-53 (12-15% rev)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFacilities\u003c\/td\u003e\n\u003ctd\u003e~85\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePayroll\u003c\/td\u003e\n\u003ctd\u003e28-32% of OPEX\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCold‑chain ops\u003c\/td\u003e\n\u003ctd\u003e35-50\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCompliance\u003c\/td\u003e\n\u003ctd\u003e8-12\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/pazenta\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eevenue Streams\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSales of Automated Storage Systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAzenta generates major revenue by selling proprietary robotic storage systems to labs and biobanks, with unit prices often ranging from $150k-$1M and contributing roughly 40-50% of hardware revenue in 2024; these high‑value capital sales give strong upfront cash and commonly convert into multi‑year service contracts and consumable sales that drove 2024 aftermarket revenue growth of about 12% year‑over‑year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRecurring Storage and Biobanking Fees\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAzenta generates steady income from multi-year off-site storage and biobanking contracts, with fees tied to sample volume and required conditions (ambient to ultra-low temperatures); recurring revenue made up about 55% of services revenue in 2024, helping offset capital-equipment cyclicality and supporting predictable cash flows-here's the quick math: a 5% annual client base growth at $120 average fee per sample yields ~$6.6M incremental ARR per 100k samples.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFee-for-Service Genomic Analysis\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eFee-for-service genomic analysis generates revenue per sample or project for sequencing, bioinformatics, and molecular services, letting clients use Azenta's HiSeq\/NextSeq-class labs without long-term contracts; in 2024 Azenta reported services revenue growth of ~12% y\/y, with multi-sample projects driving a large share of its $1.1B+ annual revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMaintenance and Technical Service Contracts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAzenta sells service contracts-maintenance, calibration, and technical support-after automated-system installations, generating recurring revenue that represented about 18% of service segment sales in 2024 and helps keep client equipment uptime above 98%.\u003c\/p\u003e\n\u003cp\u003eThese post-sale agreements boost retention and margin, with typical multi-year contracts yielding 10-20% annuity-like revenue growth annually.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRecurring revenue: ~18% of 2024 service sales\u003c\/li\u003e\n\u003cli\u003eEquipment uptime: \u0026gt;98% under contracts\u003c\/li\u003e\n\u003cli\u003eContract term: multi-year, 10-20% annual annuity growth\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLaboratory Consumables and Accessories\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAzenta sells proprietary sample tubes, racks, and consumables that fit its automated storage and handling systems; these high-margin items are purchased frequently and scale with an expanding installed base, driving recurring revenue. In 2025 Azenta reported consumables and service growth outpacing instrument sales, with consumables often yielding gross margins above 60% and creating strong customer lock-in.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh-margin consumables (\u0026gt;60% gross margin)\u003c\/li\u003e\n\u003cli\u003eFrequent repeat purchases → recurring revenue\u003c\/li\u003e\n\u003cli\u003eRevenue grows with installed base expansion\u003c\/li\u003e\n\u003cli\u003eProprietary design → strong customer lock-in\u003c\/li\u003e\n\u003cli\u003e2025: consumables\/service growth outpaced instrument sales\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAzenta: High‑ticket hardware + \u0026gt;60% GM consumables fuel recurring revenue growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAzenta earns hardware sales ($150k-$1M\/unit) plus multi-year service and consumable annuities; 2024 hardware drove ~45% of product revenue, services\/consumables ~55%, with services growing ~12% y\/y and consumables gross margins \u0026gt;60% in 2025.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHardware share\u003c\/td\u003e\n\u003ctd\u003e~45%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eServices\/consumables\u003c\/td\u003e\n\u003ctd\u003e~55%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eServices growth\u003c\/td\u003e\n\u003ctd\u003e~12% y\/y (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsumables GM\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;60% (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Value Chain Analysis","offers":[{"title":"Default Title","offer_id":57347516268875,"sku":"azenta-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1049\/6776\/6347\/files\/azenta-canvas-business-model.webp?v=1779125621","url":"https:\/\/valuechainanalysis.com\/products\/azenta-business-model-canvas","provider":"Value Chain Analysis","version":"1.0","type":"link"}